A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)

Clinical trial NCT01484496 · COMPLETED

Trial details

NCT number: NCT01484496
Sponsor: Human Genome Sciences Inc., a GSK Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2011-11-16
Primary completion: 2015-02-13
Enrollment: 839

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.